Increasing reports have suggested that upregulated CTSK could be found in patients with breast cancer [17], giant cell tumors of bone [18], prostate cancer [19] and many other types of epithelial-derived cell cancers [20,21,22]. The gene discussed is CTSK; the disease is prostate cancer.